Rv0100: An essential acyl carrier protein from M. tuberculosis important in dormancy
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304876 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Hiten J Gutka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, United States of America. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Bacterial Proteins, Acyl Carrier Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Lung Association.
Abstract (Originalsprache)
We have identified an acyl-carrier protein, Rv0100, that is up-regulated in a dormancy model. This protein plays a critical role in the fatty acid biosynthesis pathway, which is important for energy storage and cell wall synthesis in Mycobacterium tuberculosis (MTB). Knocking out the Rv0100 gene resulted in a significant reduction of growth compared to wild-type MTB in the Wayne model of non-replicating persistence. We have also shown that Rv0100 is essential for the growth and survival of this pathogen during infection in mice and a macrophage model. Furthermore, knocking out Rv0100 disrupted the synthesis of phthiocerol dimycocerosates, the virulence-enhancing lipids produced by MTB and Mycobacterium bovis . We hypothesize that this essential gene contributes to MTB virulence in the state of latent infection. Therefore, inhibitors targeting this gene could prove to be potent antibacterial agents against this pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, United States of America.
- Department of Neuropeptide Research, Central Institute for Mental Health, Mannheim, Germany.
- Department of Microbiology, School of Medicine, University of Colorado Denver, Aurora, Colorado, United States of America.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, United States of America.
ORCID-Profile: Farahnaz Movahedzadeh
Förderung
- American Lung Association
Zitieren
APA
Gutka, H. J., Bondoc, J. M. G., Patwell, R., Khan, S., Grzelak, E. M., Goswami, R., Voskuil, M. I., & Movahedzadeh, F. (2024). Rv0100: An essential acyl carrier protein from M. tuberculosis important in dormancy. PLOS ONE. https://doi.org/10.1371/journal.pone.0304876
Vancouver
Gutka HJ, Bondoc JMG, Patwell R, Khan S, Grzelak EM, Goswami R, et al. Rv0100: An essential acyl carrier protein from M. tuberculosis important in dormancy. PLOS ONE. 2024. doi:10.1371/journal.pone.0304876
BibTeX
@article{Gutka2024,
author = {Gutka, Hiten J and Bondoc, Jasper Marc G and Patwell, Ryan and Khan, Shahebraj and Grzelak, Edyta M and Goswami, Rajendra and Voskuil, Martin I and Movahedzadeh, Farahnaz},
title = {Rv0100: An essential acyl carrier protein from M. tuberculosis important in dormancy},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304876}
}
EUVIMED